Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.577 USD | +1.60% | +17.08% | +8.26% |
05-09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.26% | 118M | |
+5.92% | 111B | |
+11.80% | 106B | |
-12.62% | 22.24B | |
-0.15% | 21.25B | |
-4.83% | 18.97B | |
-35.21% | 18.52B | |
-10.44% | 16.81B | |
+37.83% | 12.54B | |
-24.85% | 8.09B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Truist Trims Price Target for Sangamo Therapeutics to $17 From $19, Maintains Buy Rating